The FDA-approved drug Pluvicto offers hope for advanced prostate cancer patients, but access barriers remain despite proven ...

There are strict rules about what drug companies can say in TV or print ads. But a new study shows there's a lot more wiggle ...

In October 2025, the U.S. Food and Drug Administration (FDA) granted approval to multiple new cancer therapies and supportive care options, covering treatments for acute myeloid leukemia (AML), ...

In any review of mifepristone, the FDA will now have to grapple with Judge Otake’s conclusion that the 2023 REMS decision for ...

The U.S. Food and Drug Administration (FDA) is warning consumers, patients and health care providers about the potential risk for serious complications from radiofrequency (RF) microneedling ...

Pharmaceutical companies are better positioned to understand what information physicians want—and how to generate it quickly ...

Elinzanetant belongs to a new class of drugs designed to target what is believed to be a key mechanism responsible for ...

FDA rewrites biosimilar rules to speed development and lower costs for biologic drugs, supporting federal drug price reduction efforts.

The U.S. Food and Drug Administration has approved elinzanetant, a new non-hormonal treatment to help women manage menopause ...

Three years after its global market withdrawal and months after a negative advisory committee vote, GSK can officially call it a comeback for its multiple myeloma drug Blenrep in the U.S., albeit w | ...

The agency’s decision to conceal drug names on inspection reports has prevented doctors, pharmacists and patients from ...

We wanted to know where a widely used prescription drug that treats high cholesterol was manufactured and whether the factory ...